184 related articles for article (PubMed ID: 34248683)
1. Hepatic Branch Vagotomy Modulates the Gut-Liver-Brain Axis in Murine Cirrhosis.
Zhang Y; Kang JD; Zhao D; Ghosh SS; Wang Y; Tai Y; Gonzalez-Maeso J; Sikaroodi M; Gillevet PM; Lippman HR; Hylemon PB; Zhou H; Bajaj JS
Front Physiol; 2021; 12():702646. PubMed ID: 34248683
[TBL] [Abstract][Full Text] [Related]
2. Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant.
Liu R; Kang JD; Sartor RB; Sikaroodi M; Fagan A; Gavis EA; Zhou H; Hylemon PB; Herzog JW; Li X; Lippman RH; Gonzalez-Maeso J; Wade JB; Ghosh S; Gurley E; Gillevet PM; Bajaj JS
Hepatology; 2020 Feb; 71(2):611-626. PubMed ID: 31220352
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice.
Kang DJ; Betrapally NS; Ghosh SA; Sartor RB; Hylemon PB; Gillevet PM; Sanyal AJ; Heuman DM; Carl D; Zhou H; Liu R; Wang X; Yang J; Jiao C; Herzog J; Lippman HR; Sikaroodi M; Brown RR; Bajaj JS
Hepatology; 2016 Oct; 64(4):1232-48. PubMed ID: 27339732
[TBL] [Abstract][Full Text] [Related]
4. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
Khound R; Taher J; Baker C; Adeli K; Su Q
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
[TBL] [Abstract][Full Text] [Related]
5. Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy.
Saboo K; Shamsaddini A; Iyer MV; Hu C; Fagan A; Gavis EA; White MB; Fuchs M; Heuman DM; Sikaroodi M; Iyer RK; Gillevet PM; Bajaj JS
J Hepatol; 2021 Jan; 74(1):80-88. PubMed ID: 32679299
[TBL] [Abstract][Full Text] [Related]
6. Posttraumatic stress disorder is associated with altered gut microbiota that modulates cognitive performance in veterans with cirrhosis.
Bajaj JS; Sikaroodi M; Fagan A; Heuman D; Gilles H; Gavis EA; Fuchs M; Gonzalez-Maeso J; Nizam S; Gillevet PM; Wade JB
Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G661-G669. PubMed ID: 31460790
[TBL] [Abstract][Full Text] [Related]
7. Bisphenol A exposure induces gut microbiota dysbiosis and consequent activation of gut-liver axis leading to hepatic steatosis in CD-1 mice.
Feng D; Zhang H; Jiang X; Zou J; Li Q; Mai H; Su D; Ling W; Feng X
Environ Pollut; 2020 Oct; 265(Pt A):114880. PubMed ID: 32540565
[TBL] [Abstract][Full Text] [Related]
8. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.
Bajaj JS; Betrapally NS; Hylemon PB; Heuman DM; Daita K; White MB; Unser A; Thacker LR; Sanyal AJ; Kang DJ; Sikaroodi M; Gillevet PM
Hepatology; 2015 Oct; 62(4):1260-71. PubMed ID: 25820757
[TBL] [Abstract][Full Text] [Related]
9. Hepatoprotective effect of curcumin against bisphenol A-induced hepatic steatosis via modulating gut microbiota dysbiosis and related gut-liver axis activation in CD-1 mice.
Hong T; Jiang X; Zou J; Yang J; Zhang H; Mai H; Ling W; Feng D
J Nutr Biochem; 2022 Nov; 109():109103. PubMed ID: 35780999
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota: its role in hepatic encephalopathy.
Rai R; Saraswat VA; Dhiman RK
J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S29-36. PubMed ID: 26041954
[TBL] [Abstract][Full Text] [Related]
11. Periodontal therapy favorably modulates the oral-gut-hepatic axis in cirrhosis.
Bajaj JS; Matin P; White MB; Fagan A; Deeb JG; Acharya C; Dalmet SS; Sikaroodi M; Gillevet PM; Sahingur SE
Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G824-G837. PubMed ID: 30118351
[TBL] [Abstract][Full Text] [Related]
12. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
[TBL] [Abstract][Full Text] [Related]
13. Maternal sucralose intake alters gut microbiota of offspring and exacerbates hepatic steatosis in adulthood.
Dai X; Guo Z; Chen D; Li L; Song X; Liu T; Jin G; Li Y; Liu Y; Ajiguli A; Yang C; Wang B; Cao H
Gut Microbes; 2020 Jul; 11(4):1043-1063. PubMed ID: 32228300
[TBL] [Abstract][Full Text] [Related]
14. Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis.
Ahluwalia V; Betrapally NS; Hylemon PB; White MB; Gillevet PM; Unser AB; Fagan A; Daita K; Heuman DM; Zhou H; Sikaroodi M; Bajaj JS
Sci Rep; 2016 May; 6():26800. PubMed ID: 27225869
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
16. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
[TBL] [Abstract][Full Text] [Related]
17. The role of microbiota in hepatic encephalopathy.
Bajaj JS
Gut Microbes; 2014; 5(3):397-403. PubMed ID: 24690956
[TBL] [Abstract][Full Text] [Related]
18. Bisphenol A induced hepatic steatosis by disturbing bile acid metabolism and FXR/TGR5 signaling pathways via remodeling the gut microbiota in CD-1 mice.
Hong T; Zou J; He Y; Zhang H; Liu H; Mai H; Yang J; Cao Z; Chen X; Yao J; Feng D
Sci Total Environ; 2023 Sep; 889():164307. PubMed ID: 37211107
[TBL] [Abstract][Full Text] [Related]
19. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy
Luo M; Xin RJ; Hu FR; Yao L; Hu SJ; Bai FH
World J Gastroenterol; 2023 Jan; 29(1):144-156. PubMed ID: 36683714
[TBL] [Abstract][Full Text] [Related]
20. Predicting Clinical Outcomes of Cirrhosis Patients With Hepatic Encephalopathy From the Fecal Microbiome.
Sung CM; Lin YF; Chen KF; Ke HM; Huang HY; Gong YN; Tsai WS; You JF; Lu MJ; Cheng HT; Lin CY; Kuo CJ; Tsai IJ; Hsieh SY
Cell Mol Gastroenterol Hepatol; 2019; 8(2):301-318.e2. PubMed ID: 31004827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
